Quality is vital because we simply cannot afford to re-do procedures. Without this, patients will be re-admitted to hospitals, have to change their medications, or have…
Speaking with government officials, it is visible that we share common ground. Enhancing access to innovation is a priority for them and for us
Our country is improving and reshaping the healthcare industry and we as GSK have the ability to participate and have a big role in this change
LatAm as a region offers many opportunities for innovation. The key point and the biggest responsibility for us in this region is to continue working to…
The UHIA will ensure full coverage for all Egyptians to all treatments! This represents an astonishing effort to cover such a large population with quality service…
Every minute, more than five people in APMA die from CVD. Each person is a parent, child, sibling, friend or colleague, so the emotional ramifications are…
Bayer Egypt probably has one of the highest growth potentials in the region
Whenever I sit with my colleagues in the pharmaceutical innovation field, I feel we speak exactly the same language. Now more than ever, we need to…
All stakeholders want to see this project succeed because it will positively affect every citizen and family in the country
Our job in LatAm is to ensure that the population in general, as well as healthcare providers and governments, understand the importance of diagnosing and treating…
Overall, the Bahraini public and private sectors worked together very well against COVID-19, collaborating to solve complex problems and reacting quickly to a dynamic and challenging…
Five of the 16 countries that together account for 85 percent of the growth of [GSK's emerging markets] region are from Latin America
See our Cookie Privacy Policy Here
